FDA leadership in clinical trial computer simulation urged in IAF report.

Executive Summary

FDA LEADERSHIP IN CLINICAL TRIAL COMPUTER SIMULATION URGED in the Institute for Alternative Future's "Clinical Development 2005" report discussed at a Capitol Hill briefing July 18. "Advances in computer simulation can contribute significantly to the process of clinical development," the report declares. Placing FDA in a leadership role to develop the concept "would be a powerful leveraging strategy that would position simulation as a new mechanism in clinical development," the report states.